510 related articles for article (PubMed ID: 27340853)
21. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.
Dumanis SB; Tesoriero JA; Babus LW; Nguyen MT; Trotter JH; Ladu MJ; Weeber EJ; Turner RS; Xu B; Rebeck GW; Hoe HS
J Neurosci; 2009 Dec; 29(48):15317-22. PubMed ID: 19955384
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
23. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.
Klein RC; Acheson SK; Mace BE; Sullivan PM; Moore SD
Neurobiol Aging; 2014 Sep; 35(9):2046-52. PubMed ID: 24698766
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
25. Effect of Chronic Cadmium Exposure on Brain and Liver Transporters and Drug-Metabolizing Enzymes in Male and Female Mice Genetically Predisposed to Alzheimer's Disease.
Wang H; Zhang L; Xia Z; Cui JY
Drug Metab Dispos; 2022 Oct; 50(10):1414-1428. PubMed ID: 35878927
[TBL] [Abstract][Full Text] [Related]
26. APOE genotype alters glial activation and loss of synaptic markers in mice.
Zhu Y; Nwabuisi-Heath E; Dumanis SB; Tai LM; Yu C; Rebeck GW; LaDu MJ
Glia; 2012 Apr; 60(4):559-69. PubMed ID: 22228589
[TBL] [Abstract][Full Text] [Related]
27. Impact of APOE genotype on prion-type propagation of tauopathy.
Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P
Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098
[TBL] [Abstract][Full Text] [Related]
28. Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.
Reverte I; Peris-Sampedro F; Basaure P; Campa L; Suñol C; Moreno M; Domingo JL; Colomina MT
Psychopharmacology (Berl); 2016 Jan; 233(2):295-308. PubMed ID: 26497539
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
30. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
Reas ET; Triebswetter C; Banks SJ; McEvoy LK
Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
[TBL] [Abstract][Full Text] [Related]
31. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.
Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P
Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275
[TBL] [Abstract][Full Text] [Related]
32. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
[TBL] [Abstract][Full Text] [Related]
33. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
35. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
[TBL] [Abstract][Full Text] [Related]
36. ApoE isoforms differentially regulates cleavage and secretion of BDNF.
Sen A; Nelson TJ; Alkon DL
Mol Brain; 2017 Jun; 10(1):19. PubMed ID: 28569173
[TBL] [Abstract][Full Text] [Related]
37. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
[TBL] [Abstract][Full Text] [Related]
39. APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology.
Meneses AD; Koga S; Li Z; O'Leary J; Li F; Chen K; Murakami A; Qiao W; Kurti A; Heckman MG; White L; Xie M; Chen Y; Finch NA; Lim MJ; Delenclos M; DeTure MA; Linares C; Martin NB; Ikezu TC; van Blitterswijk MM; Wu LJ; McLean PJ; Rademakers R; Ross OA; Dickson DW; Bu G; Zhao N
Ann Neurol; 2023 Apr; 93(4):830-843. PubMed ID: 36546684
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain.
Teter B; LaDu MJ; Sullivan PM; Frautschy SA; Cole GM
Neuroreport; 2016 Aug; 27(11):791-5. PubMed ID: 27281274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
